Page 4 - Knowledge Intensive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

When the pandemic first hit, the outlook for riskier, alternative asset investment opportunities looked bleak.

Annual Report and Accounts for the year ended 31 December 2020 Titan today announces the final results for the year to 31 December 2020 as below. These results were approved by the Board of Directors on 23 April 2021. You may view the Annual Report in full at  www.octopusinvestments.com shortly. All other statutory information will also be found there. Octopus Titan VCT plc (‘Titan’ or ‘the Company’) is a venture capital trust (‘VCT’) which aims to provide shareholders with attractive tax-free dividends and long-term capital growth by investing in a diverse portfolio of predomin...

Annual Financial Report Announcement   British Smaller Companies VCT2 plc (the "Company") today announces its audited results for the year ended 31 December 2020. HIGHLIGHTS · As announced on 28 January 2021, in the year Total Return increased by 3.3 pence to 125.0 pence per ordinary share, an increase of 6.0 per cent over the opening net asset value. · Two new investments and four follow-on investments totalling £4.0 million were completed during the year. A further two new investments totalling £2.0 million have been completed since the y...

First UK 'Knowledge Intensive' deeptech university fund January 11, 2021 // By Nick Flaherty The first UK Knowledge Intensive Funds from Parkwalk is backing deeptech university spinouts in hardware, AI and quantum UK venture capital fund Parkwalk has launched one of the first Knowledge Intensive Funds to be approved by the UK government to invest in deeptech startups. The fund will invest in ground-breaking deeptech businesses spun out of UK universities, but with a facility to carry back income tax relief to the previous tax year and reduced administration for in...

Injecting new life: How to fill the gaping hole in support for R&D intensive businesses at late-stage funding Vaccine breakthrough proves anything is possible Moray Wright of Parkwalk Advisors Moray Wright This week's rollout of the Oxford-AstraZeneca vaccine has shone a spotlight on the importance of research & development (R&D) in tackling the greatest challenges faced by humanity. It is a knowledge-intensive businesses whose years of work goes on to underpin the greatest leaps in mankind. For example, anyone who saw the BBC Panorama programme "The Race for a Vaccine" will know the science ...